Side Effects

Showing 9-16 of 30 results

DoxyPEP: What providers need to know

DoxyPEP is an emerging evidence-based, low-cost tool for STI prevention. Here's what you need to know.

2024 Updates to the U.S. SPR and U.S. MEC

New and updated guidance on the initiation and management of contraception, including pain management options for IUD placement, support for DMPA-SQ, and new conditions and methods added.

Does the route of misoprostol matter?

Answers for healthcare providers on routes of misoprostol administration and what they mean for medication abortion care.

Research roundup: November 2024 edition

Intrauterine mepivacaine for IUD placement, the impact of abortion restrictions on medical training, pregnancy of unknown location and very early medication abortion, and navigating abortion misinformation

Research roundup: October 2024 edition

LNG-IUD and the risk of gynecologic and breast cancers, contraception and body weight, and preferred ways to get hormonal birth control.

Bridging the gaps between young people’s knowledge and access

What providers need to know about the 2024 YouR HeAlth Survey to improve contraception and abortion access for young people.

Research roundup: September 2024 edition

Ongoing support for forgoing Rh testing in early pregnancy, medication abortion before six weeks, provider bias on contraceptive counseling adolescents, and local anesthesia before procedural abortion.

Research roundup: August 2024 edition

U.S. MEC and U.S. SPR, standard dosing of UPA EC for people of all body sizes, birth control information on TikTok, and safety of medication abortion without screening ultrasound.
  • Previous
  • 1
  • 2(current)
  • 3
  • 4
  • Next